title: X-ray microanalysis of myometrium in parturient women at term.
abstract: The purpose of this study was to investigate the elemental composition of myometrial cells from term parturient women with normal and dysfunctional labour. Myometrial biopsies were obtained from forty-four term pregnant women undergoing Cesarean section. The patients were categorized according to uterine activity as follows: before labour, normal labour, labour successfully augmented by oxytocin, oxytocin-resistant labour, and labour arrested by terbutaline. X-ray microanalysis of freeze-dried sections (16 mu m thick) of the myometrium was carried out. An increase in intracellular phosphorus level (p < .01) was noted in the normal labour group compared to before labour. In patients with normal labour, higher phosphorus (p < .009) and potassium (p < .005) were found compared to oxytocin resistant labour. Patients with oxytocin resistant labour had lower intracellular potassium (p < .0006) and phosphorus (p < .02), and higher chloride (p < .05) and sodium (p < .03) compared to levels found in patients who responded to oxytocin treatment. In dysfunctional (oxytocin-resistant) labour the ion distribution in the myometrial cells might be disturbed. The reduced level of potassium and phosphorus together with the high sodium and chloride levels found in patients with oxytocin resistant labour may be connected to an impairment in sodium-potassium pump and muscle dysfunction, clinically diagnosed as dystocia.
authors.affiliation: Department of Obstetrics and Gynecology, Academic Hospital, University of Uppsala, Sweden.
authors.forename: M
authors.initials: M
authors.lastname: Rezapour
authors.forename: G M
authors.initials: GM
authors.lastname: Roomans
authors.forename: T
authors.initials: T
authors.lastname: Backstrom
authors.forename: U
authors.initials: U
authors.lastname: Ulmsten
mesh_terms: D001706:Biopsy; D002118:Calcium / Q000502:physiology; D002585:Cesarean Section; D002712:Chlorides / Q000032:analysis; D004577:Electron Probe Microanalysis; D005260:Female; D005316:Fetal Distress; D006801:Humans; D007743:Labor, Obstetric / Q000187:drug effects / Q000378:metabolism*; D009215:Myometrium / Q000737:chemistry* / Q000187:drug effects / Q000648:ultrastructure; D007744:Obstetric Labor Complications / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D007752:Obstetric Labor, Premature / Q000188:drug therapy; D010121:Oxytocin / Q000627:therapeutic use; D010758:Phosphorus / Q000032:analysis; D011188:Potassium / Q000032:analysis; D011247:Pregnancy; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism*; D013726:Terbutaline / Q000494:pharmacology / Q000627:therapeutic use; D015149:Tocolytic Agents / Q000494:pharmacology / Q000627:therapeutic use; D014590:Uterine Contraction / Q000187:drug effects / Q000502:physiology
chemical_list: D002712:Chlorides; D015149:Tocolytic Agents; D010758:Phosphorus; D010121:Oxytocin; D000254:Sodium-Potassium-Exchanging ATPase; D013726:Terbutaline; D011188:Potassium; D002118:Calcium